Kutzkey Tim
SEC-identified person · CIK 1614186 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Surrozen, Inc./DE [SRZN] | Director | filed 2021 - 2026 |
| Tenaya Therapeutics, Inc. TNYA | Officer | filed 2026 - 2026 |
| Eikon Therapeutics, Inc. EIKN | Officer | filed 2026 - 2026 |
| Rapt Therapeutics, Inc. RAPT | Officer | filed 2019 - 2024 |
| NGM Biopharmaceuticals INC NGM | Officer | filed 2019 - 2024 |
| Nurix Therapeutics, Inc. NRIX | Officer | filed 2020 - 2021 |
| Constellation Pharmaceuticals INC CNST | Officer | filed 2018 - 2021 |
| Revolution Medicines, Inc. RVMD | Officer | filed 2020 - 2020 |
| Immune Design Corp. IMDZ | Officer | filed 2017 - 2019 |
| Arcus Biosciences, Inc. RCUS | Officer | filed 2018 - 2018 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.